CombinatoRx, Incorporated, a biopharmaceutical company, focuses on the development of medicines built from synergistic combinations of approved drugs. Its portfolio consists of seven product candidates targeting multiple immuno-inflammatory diseases and cancer. The company's clinical and preclinical pipeline includes treatments in development for cancer and rheumatoid arthritis. It also engages in ongoing research in respiratory, metabolic, and infectious diseases. CombinatoRx has research and development collaboration agreements with Spinal Muscular Atrophy Foundation; Accelerate Brain Cancer Cure, Inc.; Angiotech Pharmaceuticals, Inc.; CHDI, Inc.; National Institutes of Health; Cystic...
read more
QUOTE
As of 09:15PM EDT May 26, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
CRXX |
| SIC: |
-
|
| State location: |
MA |
| Sector: |
- |
| State of Inc: |
DE |
| Employees: |
73 |
| Type: |
NASDAQ |
COMBINATORX, INC (CRXX) MESSAGE BOARD
